Release Details
PTC Therapeutics to Participate at Upcoming March Investor Conferences
Cowen and Company 35th AnnualHealth Care Conference atThe Boston Marriott Copley Place inBoston, MA onMonday, March 2 nd.- 27th Annual
ROTH Conference at The Ritz Carlton inLaguna Niguel, CA onMonday March 9 th. Barclays Global Healthcare Conference at theLoews Miami Beach Hotel inMiami, FL onTuesday, March 10 th.
The company updates will be webcast live on the Events and Presentations page under the investor relations section of
About
PTC is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered, proprietary small molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are essential to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare disorders, oncology and infectious diseases. PTC has developed proprietary technologies that it applies in its drug discovery activities and in collaborations with leading biopharmaceutical companies. For more information on the company, please visit our website www.ptcbio.com.
FOR MORE INFORMATION PLEASE CONTACT: | |
Media: |
Investors: |
|
|
+1 (908) 912-9167 |
+1 (908) 912-9327 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-march-investor-conferences-300036293.html
SOURCE
News Provided by Acquire Media